This page was added on 04 June 2018.
This page was updated on [date-counter-updated-date]. View history of updates
Registered for use in children aged ≥8 weeks and in adults.
MenC — monovalent meningococcal serogroup C–tetanus toxoid conjugate vaccine
Each 0.5 mL monodose pre-filled syringe contains:
- 10 µg Neisseria meningitidis serogroup C
- 10–20 µg tetanus toxoid protein
Adsorbed onto 1.4 mg aluminium hydroxide.
For Product Information and Consumer Medicine Information about NeisVac-C visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.